CTDSPL and leukemia: Finally, dual-luciferase reporter transfection assay and western blot analysis on clinical samples and leukemia cell lines further supported that miR-99a played a potential oncogene role by targeting CTDSPL and TRIB2 in most pediatric myeloid leukemia patients.